Salivary miR-31-5p, miR-345-3p, and miR-424-3p Are Reliable Biomarkers in Patients with Oral Squamous Cell Carcinoma.
Beáta ScholtzJózsef HorváthIldikó TarCsongor KissIldikó J MártonPublished in: Pathogens (Basel, Switzerland) (2022)
If not detected early, oral squamous cell carcinoma (OSCC) has very poor prognosis, emphasizing the need for reliable early diagnostics. Saliva is considered a promising surrogate biosample for OSCC detection, because it comes into contact with many cells of the tumor mass, providing a comprehensive sampling of tumor-specific biomolecules. Although several protein- and RNA-based salivary biomarkers have been proposed for the detection of OSCC, the results of the studies show large differences. Our goal was to clarify which salivary microRNAs (miRNA) show reliably high expression in the saliva of OSCC patients, to be used as cancer-specific biomarkers, and potentially as early diagnostic biomarkers. Based on a detailed literature search, we selected six miRNAs commonly overexpressed in OSCC, and analyzed their expression in saliva samples of cancer patients and controls by real-time quantitative PCR. Our results suggest that miR-345 and miR-31-5p are consistently upregulated salivary biomarkers for OSCC, and a three-miRNA panel of miR-345, miR-31-5p, and miR-424-3p can distinguish cancer and control patients with high sensitivity.
Keyphrases
- poor prognosis
- long non coding rna
- cell proliferation
- papillary thyroid
- end stage renal disease
- systematic review
- ejection fraction
- chronic kidney disease
- newly diagnosed
- binding protein
- real time pcr
- long noncoding rna
- high resolution
- prognostic factors
- squamous cell carcinoma
- peritoneal dialysis
- lymph node metastasis
- loop mediated isothermal amplification
- young adults
- patient reported outcomes
- patient reported
- label free
- amino acid
- protein protein